Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.39 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CPA1 | P15085 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7164140 | 1.00 | GRIK1 (0.39) | GRIK1GRIK2CYP2C19CPA1CHRNB2 | |
| Ammonia Solution, Strong SCHEMBL27395046 | 0.98 | GRIK1 (0.38) | GRIK1GRIK2CYP2C19CPA1CHRNB2 | |
| SCHEMBL27924097 | 0.90 | GRIK1 (0.34) | GRIK1GRIK2CYP2C19CPA1CHRNB2 | |
| Glycinebetaine SCHEMBL934122 | 0.83 | CPA1 (0.33) | GRIK1GRIK2CPA1 | |
| SCHEMBL1583283 | 0.81 | GRIK1 (0.36) | GRIK1GRIK2CYP2C19CPA1 | |
| SCHEMBL2973406 | 0.81 | GRIK1 (0.36) | GRIK1GRIK2CYP2C19CPA1 | |
| SCHEMBL491045 | 0.81 | GRIK1 (0.32) | GRIK1GRIK2CYP2C19CPA1 | |
| SCHEMBL2973400 | 0.81 | GRIK1 (0.36) | GRIK1GRIK2CYP2C19CPA1 | |
| SCHEMBL30053640 | 0.79 | CHRNB2 (0.32) | CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL9683571 | 0.78 | GRIK1 (0.37) | GRIK1GRIK2CYP2C19CPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 513 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112513637-A | Kit for detecting biofilm and method for detecting biofilm | 莎罗雅株式会社 | 2021-03-16 | — | — | CN | claimed |
| WO-2019189124-A1 | POLISHING COMPOSITION | 株式会社フジミインコーポレーテッド | 2019-10-03 | — | — | WO | claimed |
| CN-101839123-B | Exploitation method for wax precipitation oil reservoir | LI XIANGDONG | 2013-07-10 | — | — | CN | claimed |
| US-8288329-B2 | Hair-treatment composition and hair-treatment method using same | HOYU CO., LTD (JP) | 2012-10-16 | — | — | US | claimed |
| US-8211879-B2 | Cationic steroid antimicrobial compositions and methods of use | BRIGHAM YOUNG UNIVERSITY (US) | 2012-07-03 | — | — | US | claimed |
| US-20120100091-A1 | HAIR-TREATMENT COMPOSITION AND HAIR-TREATMENT METHOD USING SAME | HOYU CO., LTD. (JP) | 2012-04-26 | — | — | US | claimed |
| CN-101839127-A | Exploitation method of thick oil type oil deposit | BEIJING ORIENT ASIA PETROLEUM TECHNOLOGY SERVICE CO LTD | 2010-09-22 | — | — | CN | claimed |
| CN-101839123-A | Exploitation method for wax precipitation oil reservoir | Beijing east asia petroleum technology service co ltd | 2010-09-22 | — | — | CN | claimed |
| US-20090257963-A1 | METHOD FOR MEASURABLY IMPROVING ORAL HEALTH | ZICARE, LLC (US) | 2009-10-15 | — | — | US | claimed |
| EP-1550669-B1 | Refolded membrane protein in monodisperse form | PHASYS GMBH M (DE) | 2008-08-06 | — | — | EP | claimed |
| WO-2001014407-A2 | REFOLDING OF MEMBRANE PROTEINS, USING TWO DIFFERENT DETERGENTS | M-PHASYS GMBH (DE) | 2001-03-01 | — | — | WO | claimed |
| EP-1043020-A1 | MEDICINAL COMPOSITION FOR PERCUTANEOUS ADMINISTRATION | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2000-10-11 | — | — | EP | claimed |
| CN-1211193-A | Contraceptive release systems with antibacterial and/or antiviral effect | SCHERING AG (DE) | 1999-03-17 | — | — | CN | claimed |
| EP-0511611-B1 | Liquid herbicidal compositions | HOECHST SCHERING AGREVO GMBH (DE) | 1996-02-28 | — | — | EP | claimed |
| US-5491125-A | HIGH LOW-TEMPERATURE STABILITY AND RAIN RESISTANCE | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-02-13 | — | — | US | claimed |
| EP-0576425-A1 | METHOD FOR INACTIVATING ENVELOPED VIRUSES AND SPERM | E.B. MICHAELS RESEARCH ASSOCIATES, INC. (US) | 1994-01-05 | — | — | EP | claimed |
| US-5258358-A | PLANT GROWTH REGULATORS | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-11-02 | — | — | US | claimed |
| WO-1992016201-A1 | METHOD FOR INACTIVATING ENVELOPED VIRUSES AND SPERM | E.B. MICHAELS RESEARCH ASSOCIATES, INC. (US) | 1992-10-01 | — | — | WO | claimed |
| US-4252656-A | AEROSOL CONTAINING CATIONIC POLYMER, SOFTENING AND FOAMING AGENTS, STABILIZER, HUMECTANT, WATER, AND PROPELLANT; LAUNDRY DRIERS | COLGATE-PALMOLIVE COMPANY (US) | 1981-02-24 | — | — | US | claimed |
| US-4041205-A | SURFACTANTS AND A REINFORCEMENT SELECTED FROM CELLULOSE, PROTEIN, AND NYLON | COLGATE-PALMOLIVE COMPANY (US) | 1977-08-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120100091-A1 | HAIR-TREATMENT COMPOSITION AND HAIR-TREATMENT METHOD USING SAME | AADAT, BHMT2, BCAT2 | GRIK1 1193/4885GRIK2 1380/4885CYP2C19 1972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.